LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 37 filers reported holding LUMOS PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $68,631 | -17.8% | 29,587 | -0.1% | 0.00% | – |
Q1 2024 | $83,519 | +71.5% | 29,617 | +90.3% | 0.00% | – |
Q4 2023 | $48,706 | -5.2% | 15,564 | 0.0% | 0.00% | – |
Q3 2023 | $51,393 | -22.5% | 15,564 | -22.5% | 0.00% | – |
Q2 2023 | $66,328 | -2.6% | 20,089 | 0.0% | 0.00% | – |
Q1 2023 | $68,081 | +90674.7% | 20,089 | -3.1% | 0.00% | – |
Q4 2022 | $75 | -100.0% | 20,731 | 0.0% | 0.00% | – |
Q3 2022 | $184,000 | +15.0% | 20,731 | 0.0% | 0.00% | – |
Q2 2022 | $160,000 | -18.4% | 20,731 | 0.0% | 0.00% | – |
Q1 2022 | $196,000 | +36.1% | 20,731 | 0.0% | 0.00% | – |
Q4 2021 | $144,000 | -27.6% | 20,731 | -1.1% | 0.00% | – |
Q3 2021 | $199,000 | -49.2% | 20,953 | -46.8% | 0.00% | – |
Q2 2021 | $392,000 | -19.2% | 39,405 | -5.0% | 0.00% | – |
Q1 2021 | $485,000 | -68.8% | 41,459 | -4.8% | 0.00% | -100.0% |
Q4 2020 | $1,555,000 | +157.0% | 43,548 | -0.5% | 0.00% | – |
Q3 2020 | $605,000 | -10.8% | 43,763 | +6.5% | 0.00% | – |
Q2 2020 | $678,000 | +131.4% | 41,095 | +19.1% | 0.00% | – |
Q1 2020 | $293,000 | – | 34,499 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 407,192 | $14,540,000 | 2.80% |
Opaleye Management Inc. | 281,287 | $10,045,000 | 1.31% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,291 | $33,435,000 | 0.66% |
NEA Management Company, LLC | 526,663 | $18,807,000 | 0.50% |
Investors Financial Group, LLC | 18,200 | $650,000 | 0.43% |
One68 Global Capital, LLC | 5,855 | $209,000 | 0.42% |
Wealth Advisors of Iowa, LLC | 11,760 | $420,000 | 0.26% |
Blackstone Inc. | 468,145 | $16,717,000 | 0.06% |
Foster Group, Inc. | 7,283 | $221,000 | 0.04% |
Texas Yale Capital Corp. | 16,000 | $571,000 | 0.04% |